ADAMTS5 is a biomarker for prediction of response to infliximab in patients with rheumatoid arthritis.

Details

Language :

English

ISSN :

0315162X

Volume :

37

Issue :

7

Database :

Supplemental Index

Journal :

Journal of Rheumatology

Publication Type :

Academic Journal

Accession number :

105057843

Full Text :

https://doi.org/10.3899/jrheum.091285